"Name","Gene.s.","Protein.change","Condition.s.","Clinical.significance..Last.reviewed.","Review.status","Accession","GRCh37Chromosome","GRCh37Location","GRCh38Chromosome","GRCh38Location","VariationID","AlleleID.s.","dbSNP.ID","Canonical.SPDI"
"0","0","0","0","0","0","0","0","0","0","0",0,"0","0","0"
"NM_002506.2(NGF):c.661C>T (p.Arg221Trp)","NGF|NGF-AS1","R211W, R221W","Congenital sensory neuropathy with selective loss of small myelinated fibers","Pathogenic(Last reviewed: Feb 1, 2011)","no assertion criteria provided","VCV000014045","1","115828756","1","115286135",14045,"29084","rs11466112","NC_000001.11:115286134:G:A"
"NM_170707.4(LMNA):c.1445G>A (p.Arg482Gln)","LMNA","R482Q, R370Q, R401Q","Hutchinson-Gilford syndrome|Heart-hand syndrome, Slovenian type|Mandibuloacral dysplasia with type A lipodystrophy|Charcot-Marie-Tooth disease type 2B1|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Congenital muscular dystrophy, LMNA-related|Familial partial lipodystrophy 2|Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Laminopathy|Monogenic diabetes|not provided|Cardiomyopathy|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease, type 2|Familial partial lipodystrophy 2","Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2020)","criteria provided, conflicting interpretations","VCV000014486","1","156106776","1","156136985",14486,"29525","rs11575937","NC_000001.11:156136984:G:A"
"NM_170707.4(LMNA):c.1445G>T (p.Arg482Leu)","LMNA","R482L, R370L, R401L","Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Congenital muscular dystrophy, LMNA-related|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease type 2B1|Mandibuloacral dysplasia with type A lipodystrophy|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A|not provided|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules","Uncertain significance(Last reviewed: Jan 9, 2019)","criteria provided, single submitter","VCV000014490","1","156106776","1","156136985",14490,"29529","rs11575937","NC_000001.11:156136984:G:T"
"NM_000702.4(ATP1A2):c.2291T>C (p.Leu764Pro)","ATP1A2","L764P","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012917","1","160105635","1","160135845",12917,"27956","rs28933398","NC_000001.11:160135844:T:C"
"NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr)","ATP1A2","M731T","Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Jan 13, 2012)","no assertion criteria provided","VCV000012919","1","160105300","1","160135510",12919,"27958","rs28933400","NC_000001.11:160135509:T:C"
"NM_001007792.1(NTRK1):c.1702C>T (p.His568Tyr)","NTRK1","H598Y, H568Y, H604Y","not specified|not provided|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037077","1","156848918","1","156879126",37077,"38397","rs6336","NC_000001.11:156879125:C:T"
"NM_000157.4(GBA):c.680A>G (p.Asn227Ser)","GBA|LOC106627981","N227S, N140S, N178S","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004314","1","155208006","1","155238215",4314,"19353","rs364897","NC_000001.11:155238214:T:C"
"NM_000157.3(GBA):c.1448T>C","GBA|LOC106627981","L483P, L396P, L434P","not provided|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Gaucher disease|Dementia, Lewy body, susceptibility to|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Thoracolumbar scoliosis|Resting tremor|Parkinsonism|Hypomimic face|Movement disorder","Pathogenic, risk factor(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004288","1","155205043","1","155235252",4288,"19327","rs421016","NC_000001.11:155235251:A:G"
"NM_000157.4(GBA):c.259C>T (p.Arg87Trp)","GBA|LOC106627981","R87W","Gaucher disease|Gaucher disease type I|not provided","Pathogenic(Last reviewed: Feb 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004321","1","155209725","1","155239934",4321,"19360","rs1141814","NC_000001.11:155239933:G:A"
"NM_000130.4(F5):c.1601G>A (p.Arg534Gln)","F5","","not specified|Thrombophilia due to factor V Leiden|Factor V deficiency|Ischemic stroke, susceptibility to|Budd-Chiari syndrome, susceptibility to|Pregnancy loss, recurrent, susceptibility to, 1|Thrombophilia due to factor V Leiden|Factor V deficiency","Pathogenic, risk factor(Last reviewed: Feb 22, 2021)","criteria provided, multiple submitters, no conflicts","VCV000000642","1","169519049","1","169549811",642,"15681","rs6025","NC_000001.11:169549810:C:T"
"NM_001008216.2(GALE):c.937C>A (p.Leu313Met)","GALE","L313M","UDPglucose-4-epimerase deficiency","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000003680","1","24122692","1","23796202",3680,"18719","rs3180383","NC_000001.11:23796201:G:T"
"NM_005263.5(GFI1):c.1208A>G (p.Lys403Arg)","GFI1","K403R","Neutropenia, nonimmune chronic idiopathic, of adults|Severe congenital neutropenia 2, autosomal dominant","Likely benign(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000008740","1","92941647","1","92476090",8740,"23779","rs28936382","NC_000001.11:92476089:T:C"
"NM_000098.3(CPT2):c.1883A>C (p.Tyr628Ser)","CPT2","Y628S, Y605S","Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile","Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008956","1","53679173","1","53213501",8956,"23995","rs28936673","NC_000001.11:53213500:A:C"
"NM_000098.3(CPT2):c.520G>A (p.Glu174Lys)","CPT2","E174K","Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyltransferase II deficiency, infantile","Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008957","1","53675866","1","53210194",8957,"23996","rs28936674","NC_000001.11:53210193:G:A"
"NM_000642.3(AGL):c.4459C>T (p.Arg1487Ter)","AGL","R1487*, R1471*","Glycogen storage disease type III|Glycogen storage disease","Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)","criteria provided, conflicting interpretations","VCV000456508","1","100382265","1","99916709",456508,"448519","rs12118058","NC_000001.11:99916708:C:T"
"NM_002016.1(FLG):c.3551C>A (p.Ser1184Ter)","FLG","S1184*","not provided","Pathogenic(Last reviewed: Jul 15, 2015)","criteria provided, single submitter","VCV000419209","1","152283811","1","152311335",419209,"404917","rs3120649","NC_000001.11:152311334:G:T"
"NM_018116.3(MSTO1):c.971C>T (p.Thr324Ile)","MSTO1","T324I, T146I, T147I, T143I, T269I","Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2021)","criteria provided, conflicting interpretations","VCV000438833","1","155582639","1","155612848",438833,"432466","rs622288","NC_000001.11:155612847:C:T"
"NM_000098.3(CPT2):c.520G>T (p.Glu174Ter)","CPT2","E174*","Carnitine palmitoyltransferase II deficiency, infantile","Likely pathogenic(Last reviewed: Jan 26, 2017)","criteria provided, single submitter","VCV000550520","1","53675866","1","53210194",550520,"541317","rs28936674","NC_000001.11:53210193:G:T"
"NM_006516.3(SLC2A1):c.1372C>A (p.Arg458=)","SLC2A1","","History of neurodevelopmental disorder|GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|not specified|Dystonia 9","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000139167","1","43392819","1","42927148",139167,"142870","rs13306758","NC_000001.11:42927147:G:T"
"NM_000157.4(GBA):c.475C>T (p.Arg159Trp)","GBA|LOC106627981","R159W, R110W, R72W","Gaucher disease|not provided","Pathogenic(Last reviewed: Dec 3, 2019)","criteria provided, multiple submitters, no conflicts","VCV000065570","1","155208421","1","155238630",65570,"76478","rs439898","NC_000001.11:155238629:G:A"
"NM_006516.3(SLC2A1):c.1372C>T (p.Arg458Trp)","SLC2A1","R458W","Dystonia 9|GLUT1 deficiency syndrome 2|Epilepsy, idiopathic generalized, susceptibility to, 12|Stomatin-deficient cryohydrocytosis with neurologic defects|GLUT1 deficiency syndrome 1|not provided|Epilepsy, idiopathic generalized, susceptibility to, 12|GLUT1 deficiency syndrome 1, autosomal recessive","Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)","criteria provided, multiple submitters, no conflicts","VCV000096708","1","43392819","1","42927148",96708,"102597","rs13306758","NC_000001.11:42927147:G:A"
"NM_000350.3(ABCA4):c.4685T>C (p.Ile1562Thr)","ABCA4","I1562T","Stargardt disease|Cone-rod dystrophy 3|Retinal dystrophy|not provided|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|Cone-rod dystrophy|ABCA4-Related Disorders|Stargardt disease 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000099311","1","94487490","1","94021934",99311,"105200","rs1762111","NC_000001.11:94021933:A:G"
"NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)","GBA|LOC106627981","L483R, L434R, L396R","not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease","Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093449","1","155205043","1","155235252",93449,"99356","rs421016","NC_000001.11:155235251:A:C"
"NM_000157.4(GBA):c.681T>G (p.Asn227Lys)","GBA|LOC106627981","N227K, N140K, N178K","Gaucher disease type II|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type III|not provided|Gaucher disease","Pathogenic(Last reviewed: May 26, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093458","1","155208005","1","155238214",93458,"99363","rs381418","NC_000001.11:155238213:A:C"
"NM_000350.3(ABCA4):c.3377T>C (p.Leu1126Pro)","ABCA4","L1126P","Stargardt disease 1","Likely pathogenic(Last reviewed: Jan 1, 2016)","criteria provided, single submitter","VCV000236101","1","94506910","1","94041354",236101,"237679","rs1047376","NC_000001.11:94041353:A:G"
"NM_000130.5(F5):c.1601= (p.Arg534=)","F5","","Factor V deficiency|not provided|hormonal contraceptives for systemic use response - Toxicity/ADR","drug response(Last reviewed: Nov 28, 2017)","reviewed by expert panel","VCV000226007","1","169519049","1","169549811",226007,"227743","rs6025","NC_000001.11:169549810:C:C"
"NM_001083116.3(PRF1):c.673C>T (p.Arg225Trp)","PRF1","R225W","Familial hemophagocytic lymphohistiocytosis 2","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000013711","10","72358804","10","70599048",13711,"28750","rs28933973","NC_000010.11:70599047:G:A"
"CYP2C19*4A/*11","CYP2C19","R150H","Citalopram response|Voriconazole response|Sertraline response|Escitalopram response","drug response","practice guideline","VCV000634361","10","96535264","10","94775507",634361,"622288","rs58973490","NC_000010.11:94775506:G:A"
"CYP2C19*4A/*35","CYP2C19","","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634019","10","96535124","10","94775367",634019,"622287","rs12769205","NC_000010.11:94775366:A:G"
"CYP2C19*4A/*14","CYP2C19","L17P","Citalopram response|Escitalopram response|Voriconazole response|Sertraline response","drug response","practice guideline","VCV000634159","10","96522512","10","94762755",634159,"622280","rs55752064","NC_000010.11:94762754:T:C"
"CYP2C19*4A/*32","CYP2C19","H99R","Escitalopram response|Sertraline response|Voriconazole response|Citalopram response","drug response","practice guideline","VCV000634162","10","96534942","10","94775185",634162,"622286","rs1288601658","NC_000010.11:94775184:A:G"
"CYP2C19*4A/*10","CYP2C19","P227L","Voriconazole response|Sertraline response|Escitalopram response|Citalopram response","drug response","practice guideline","VCV000633981","10","96541615","10","94781858",633981,"47951","rs6413438","NC_000010.11:94781857:C:T"
"CYP2C19*4A/*16","CYP2C19","R442C","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000633982","10","96612522","10","94852765",633982,"622295","rs192154563","NC_000010.11:94852764:C:T"
"NM_000518.4(HBB):c.20A>C (p.Glu7Ala)","LOC106099062|LOC107133510|HBB","E7A","HEMOGLOBIN G (MAKASSAR)","other(Last reviewed: Dec 12, 2017)","no assertion criteria provided","VCV000015175","11","5248232","11","5227002",15175,"30214","rs334","NC_000011.10:5227001:T:G"
"NM_000518.5(HBB):c.20A>T (p.Glu7Val)","HBB|LOC106099062|LOC107133510","E7V","HEMOGLOBIN S|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|not provided|none provided|Anemia|Hb SS disease|Sickle cell disease and related diseases|Malaria, resistance to|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Erythrocytosis 6, familial|Methemoglobinemia, beta-globin type|Susceptibility to malaria|alpha Thalassemia|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia|beta Thalassemia|Inborn genetic diseases|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Susceptibility to malaria|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000015333","11","5248232","11","5227002",15333,"30372","rs334","NC_000011.10:5227001:T:A"
"NM_000260.4(MYO7A):c.635G>A (p.Arg212His)","MYO7A","R212H, R201H","Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|not provided|Usher syndrome, type 1B|Retinal dystrophy","Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011850","11","76867950","11","77156904",11850,"26889","rs28934610","NC_000011.10:77156903:G:A"
"NM_000207.3(INS):c.266G>A (p.Arg89His)","INS|INS-IGF2","R89H","not provided|Hyperproinsulinemia","Pathogenic(Last reviewed: Jan 1, 2020)","criteria provided, single submitter","VCV000013380","11","2181149","11","2159919",13380,"28419","rs28933985","NC_000011.10:2159918:C:T"
"NM_000207.3(INS):c.266G>T (p.Arg89Leu)","INS-IGF2|INS","R89L","Hyperproinsulinemia","Pathogenic(Last reviewed: Jun 1, 1992)","no assertion criteria provided","VCV000013382","11","2181149","11","2159919",13382,"28421","rs28933985","NC_000011.10:2159918:C:A"
"NM_000207.3(INS):c.266G>C (p.Arg89Pro)","INS|INS-IGF2","R89P","Hyperproinsulinemia","Pathogenic(Last reviewed: May 1, 1997)","no assertion criteria provided","VCV000013383","11","2181149","11","2159919",13383,"28422","rs28933985","NC_000011.10:2159918:C:G"
"NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)","HRAS|LRRC56","Q61K","not provided|Noonan syndrome 3|Lip and oral cavity carcinoma|Spermatocytic seminoma|Breast neoplasm|Thyroid cancer, nonmedullary, 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)","criteria provided, multiple submitters, no conflicts","VCV000012601","11","533875","11","533875",12601,"27640","rs28933406","NC_000011.10:533874:G:T"
"NM_000256.3(MYBPC3):c.2992C>G (p.Gln998Glu)","MYBPC3","Q998E","Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Left ventricular noncompaction 10|Primary dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy|none provided|Familial hypertrophic cardiomyopathy 4|not specified","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000036610","11","47355475","11","47333924",36610,"45272","rs11570112","NC_000011.10:47333923:G:C"
"NM_000039.2(APOA1):c.341T>C (p.Leu114Pro)","APOA1|APOA1-AS","L90P, L114P, L5P","Amyloidosis, cardiac and cutaneous","Pathogenic(Last reviewed: Jan 1, 1999)","no assertion criteria provided","VCV000017931","11","116706987","11","116836271",17931,"32970","rs28931575","NC_000011.10:116836270:A:G"
"NM_001814.6(CTSC):c.1235A>G (p.Tyr412Cys)","CTSC","Y412C","Periodontitis, aggressive, 1","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000007300","11","88027331","11","88294163",7300,"22339","rs28937571","NC_000011.10:88294162:T:C"
"NM_003356.4(UCP3):c.208C>T (p.Arg70Trp)","UCP3","R70W","Obesity, severe, and type II diabetes","Pathogenic(Last reviewed: Sep 2, 2008)","no assertion criteria provided","VCV000007579","11","73717343","11","74006298",7579,"22618","rs17848368","NC_000011.10:74006297:G:A"
"NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)","TYR","R402Q","not provided|Oculocutaneous albinism type 1B|Skin/hair/eye pigmentation, variation in, 3|Cutaneous malignant melanoma 8|Skin/hair/eye pigmentation 3, blue/green eyes|Tyrosinase-negative oculocutaneous albinism|Autosomal recessive ocular albinism|Albinism|Foveal hypoplasia|Abnormality of metabolism/homeostasis|Choroidal neovascularization|Slow decrease in visual acuity|Elevated hepatic transaminases|Oculocutaneous albinism type 1, temperature sensitive|not specified|Malignant tumor of breast|Oculocutaneous albinism","Conflicting interpretations of pathogenicity, other(Last reviewed: Nov 26, 2020)","criteria provided, conflicting interpretations","VCV000003779","11","89017961","11","89284793",3779,"18818","rs1126809","NC_000011.10:89284792:G:A"
"NM_000352.6(ABCC8):c.4477C>T (p.Arg1493Trp)","ABCC8","R1494W, R1493W, R1515W, R1492W","Hyperinsulinemic hypoglycemia, familial, 1|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009096","11","17415881","11","17394334",9096,"24135","rs28936371","NC_000011.10:17394333:G:A"
"NM_005343.4(HRAS):c.181C>G (p.Gln61Glu)","HRAS|LRRC56","Q61E","Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Chronic lymphocytic leukemia|Hepatocellular carcinoma|Squamous cell lung carcinoma|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Malignant melanoma of skin|Adenocarcinoma of stomach|Acute myeloid leukemia|Pancreatic adenocarcinoma|Multiple myeloma","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376444","11","533875","11","533875",376444,"363323","rs28933406","NC_000011.10:533874:G:C"
"NM_000256.3(MYBPC3):c.2992C>T (p.Gln998Ter)","MYBPC3","Q998*","not provided|Hypertrophic cardiomyopathy","Pathogenic(Last reviewed: Feb 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000180993","11","47355475","11","47333924",180993,"179222","rs11570112","NC_000011.10:47333923:G:A"
"NM_004588.5(SCN2B):c.82C>T (p.Arg28Trp)","SCN2B","R28W","not provided|Atrial fibrillation, familial, 14","Uncertain significance(Last reviewed: Feb 6, 2017)","criteria provided, single submitter","VCV000060769","11","118039455","11","118168740",60769,"75311","rs17121819","NC_000011.10:118168739:G:A"
"NM_000518.5(HBB):c.*132+101G>C","HBB|LOC107133510|LOC110006319","","not provided|not specified|beta Thalassemia","Benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256341","11","5246595","11","5225365",256341,"254202","rs12788013","NC_000011.10:5225364:C:G"
"NM_000217.3(KCNA1):c.731C>A (p.Pro244His)","KCNA1","P244H","Myokymia 1","Pathogenic(Last reviewed: Oct 1, 2000)","no assertion criteria provided","VCV000013490","12","5021275","12","4912109",13490,"28529","rs28933382","NC_000012.12:4912108:C:A"
"NM_000545.6(HNF1A):c.1720G>A (p.Gly574Ser)","HNF1A","G574S","not specified|not provided|Maturity-onset diabetes of the young, type 3","Benign(Last reviewed: Nov 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000014939","12","121437382","12","120999579",14939,"29978","rs1169305","NC_000012.12:120999578:A:A"
"NM_001065.4(TNFRSF1A):c.362G>C (p.Arg121Pro)","TNFRSF1A","R92P, R121P, R13P","TNF receptor-associated periodic fever syndrome (TRAPS)","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000012341","12","6442643","12","6333477",12341,"27380","rs4149584","NC_000012.12:6333476:C:G"
"NM_000545.8(HNF1A):c.1720A>G (p.Ser574Gly)","HNF1A","S581G, S574G","not provided|not specified|Maturity-onset diabetes of the young, type 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000036810","12","121437382","12","120999579",36810,"45471","rs1169305","NC_000012.12:120999578:A:G"
"NM_020638.3(FGF23):c.535C>T (p.Arg179Trp)","FGF23","R179W","not provided|Autosomal dominant hypophosphatemic rickets","Likely pathogenic(Last reviewed: Nov 20, 2015)","criteria provided, single submitter","VCV000005026","12","4479730","12","4370564",5026,"20065","rs28937882","NC_000012.12:4370563:G:A"
"NM_000017.4(ACADS):c.511C>T (p.Arg171Trp)","ACADS","R171W","not provided|Deficiency of butyryl-CoA dehydrogenase","Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)","criteria provided, conflicting interpretations","VCV000003830","12","121175678","12","120737875",3830,"18869","rs1800556","NC_000012.12:120737874:C:T"
"NM_000277.3(PAH):c.754C>T (p.Arg252Trp)","PAH","R252W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000584","12","103246681","12","102852903",584,"15623","rs5030847","NC_000012.12:102852902:G:A"
"NM_000277.3(PAH):c.1066-11G>A","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Oct 1, 2018)","reviewed by expert panel","VCV000000607","12","103237568","12","102843790",607,"15646","rs5030855","NC_000012.12:102843789:C:T"
"NM_000277.3(PAH):c.143T>C (p.Leu48Ser)","PAH","L48S","not provided|Phenylketonuria","Pathogenic(Last reviewed: Apr 8, 2019)","reviewed by expert panel","VCV000000608","12","103306594","12","102912816",608,"15647","rs5030841","NC_000012.12:102912815:A:G"
"NM_000277.3(PAH):c.1222C>T (p.Arg408Trp)","PAH","R408W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 6, 2018)","reviewed by expert panel","VCV000000577","12","103234271","12","102840493",577,"15616","rs5030858","NC_000012.12:102840492:G:A"
"NM_000277.3(PAH):c.754C>G (p.Arg252Gly)","PAH","R252G","not provided|Phenylketonuria","Pathogenic(Last reviewed: Dec 8, 2018)","reviewed by expert panel","VCV000102823","12","103246681","12","102852903",102823,"108559","rs5030847","NC_000012.12:102852902:G:C"
"NM_001065.4(TNFRSF1A):c.362G>A (p.Arg121Gln)","TNFRSF1A","R121Q, R13Q","TNF receptor-associated periodic fever syndrome (TRAPS)|Multiple sclerosis, susceptibility to, 5|not specified|none provided|TNF receptor-associated periodic fever syndrome (TRAPS)|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)","criteria provided, conflicting interpretations","VCV000217017","12","6442643","12","6333477",217017,"213624","rs4149584","NC_000012.12:6333476:C:T"
"NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=)","BRCA2","","Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Tracheoesophageal fistula|Familial cancer of breast|not provided|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Familial cancer of breast|Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Nov 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000038215","13","32954050","13","32379913",38215,"46771","rs28897756","NC_000013.11:32379912:G:A"
"NM_000059.3(BRCA2):c.9117G>C (p.Pro3039=)","BRCA2","","not specified","Uncertain significance(Last reviewed: Sep 11, 2017)","criteria provided, single submitter","VCV000632708","13","32954050","13","32379913",632708,"621449","rs28897756","NC_000013.11:32379912:G:C"
"NM_000059.3(BRCA2):c.9117G>T (p.Pro3039=)","BRCA2","","Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2021)","criteria provided, conflicting interpretations","VCV000267715","13","32954050","13","32379913",267715,"262852","rs28897756","NC_000013.11:32379912:G:T"
"NM_000257.4(MYH7):c.5533C>T (p.Arg1845Trp)","MYH7","R1845W","not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy|Myosin storage myopathy","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000014114","14","23884230","14","23415021",14114,"29153","rs28933098","NC_000014.9:23415020:G:A"
"NM_020529.2(NFKBIA):c.95G>T (p.Ser32Ile)","NFKBIA","S32I","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Sep 6, 2004)","no assertion criteria provided","VCV000014003","14","35873756","14","35404550",14003,"29042","rs28933100","NC_000014.9:35404549:C:A"
"NM_000257.4(MYH7):c.1207C>T (p.Arg403Trp)","MYH7","R403W","not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype|MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Familial hypertrophic cardiomyopathy 1|Myopathy, distal, 1|Dilated cardiomyopathy 1S|Myosin storage myopathy","Pathogenic(Last reviewed: Dec 15, 2016)","reviewed by expert panel","VCV000014102","14","23898488","14","23429279",14102,"29141","rs3218714","NC_000014.9:23429278:G:A"
"NM_001127701.1(SERPINA1):c.194T>C (p.Leu65Pro)","SERPINA1","L65P","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI M(PROCIDA)|not provided|Alpha-1-antitrypsin deficiency","Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017971","14","94849381","14","94383044",17971,"33010","rs28931569","NC_000014.9:94383043:A:G"
"NM_000021.4(PSEN1):c.1229G>A (p.Cys410Tyr)","PSEN1","C410Y, C406Y","Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3","Pathogenic(Last reviewed: Nov 16, 2017)","criteria provided, single submitter","VCV000018127","14","73683933","14","73217225",18127,"33166","rs661","NC_000014.9:73217224:G:A"
"NM_020366.3(RPGRIP1):c.2480G>T (p.Arg827Leu)","RPGRIP1","R827L","not provided|Cone-rod dystrophy 13","Pathogenic(Last reviewed: May 2, 2013)","no assertion criteria provided","VCV000004986","14","21794102","14","21325943",4986,"20025","rs28937883","NC_000014.9:21325942:G:T"
"NM_000369.5(TSHR):c.1897G>C (p.Asp633His)","TSHR","D633H","THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC","Pathogenic(Last reviewed: Mar 1, 1997)","no assertion criteria provided","VCV000006437","14","81610299","14","81143955",6437,"21476","rs28937584","NC_000014.9:81143954:G:C"
"NM_000257.4(MYH7):c.1207C>G (p.Arg403Gly)","MYH7","R403G","Hypertrophic cardiomyopathy","Likely pathogenic(Last reviewed: Jan 9, 2017)","criteria provided, single submitter","VCV000505562","14","23898488","14","23429279",505562,"497452","rs3218714","NC_000014.9:23429278:G:C"
"NM_020529.2(NFKBIA):c.95G>A (p.Ser32Asn)","NFKBIA","S32N","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Nov 15, 2018)","no assertion criteria provided","VCV000590311","14","35873756","14","35404550",590311,"581252","rs28933100","NC_000014.9:35404549:C:T"
"NM_000326.5(RLBP1):c.700C>T (p.Arg234Trp)","RLBP1","R234W","Bothnia retinal dystrophy|RLBP1-Related Disorders|none provided|not provided|Retinitis pigmentosa|Retinitis punctata albescens","Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013100","15","89754025","15","89210794",13100,"28139","rs28933990","NC_000015.10:89210793:G:A"
"NM_014249.4(NR2E3):c.932G>A (p.Arg311Gln)","NR2E3","R311Q","Retinal dystrophy|not provided|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 37|Goldmann-Favre syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000005532","15","72105913","15","71813573",5532,"20571","rs28937873","NC_000015.10:71813572:G:A"
"NM_000138.4(FBN1):c.3963A>G (p.Thr1321=)","FBN1","","Marfan syndrome|Cardiovascular phenotype","Likely pathogenic(Last reviewed: Sep 17, 2015)","criteria provided, single submitter","VCV000520237","15","48773853","15","48481656",520237,"510594","rs140648","NC_000015.10:48481655:T:C"
"NM_002386.3(MC1R):c.478C>T (p.Arg160Trp)","MC1R","R160W","not specified|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Malignant tumor of breast|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014310","16","89986144","16","89919736",14310,"29349","rs1805008","NC_000016.10:89919735:C:T"
"NM_000548.5(TSC2):c.1832G>A (p.Arg611Gln)","TSC2","R611Q, R411Q, R622Q, R574Q, R562Q","Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Focal cortical dysplasia type II|Lymphangiomyomatosis","Pathogenic(Last reviewed: Sep 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012397","16","2120572","16","2070571",12397,"27436","rs28934872","NC_000016.10:2070570:G:A"
"NM_021615.5(CHST6):c.521A>G (p.Lys174Arg)","CHST6","K174R","Macular corneal dystrophy","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000005071","16","75513206","16","75479308",5071,"20110","rs28937877","NC_000016.10:75479307:T:C"
"NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)","CHST6","L200R","not provided|Macular corneal dystrophy|Macular corneal dystrophy, type II","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000005075","16","75513128","16","75479230",5075,"20114","rs28937879","NC_000016.10:75479229:A:C"
"NM_000243.3(MEFV):c.442G>C","MEFV","","Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)","criteria provided, conflicting interpretations","VCV000002542","16","3304626","16","3254626",2542,"17581","rs3743930","NC_000016.10:3254625:C:G"
"NM_001126108.2(SLC12A3):c.1261T>C (p.Cys421Arg)","SLC12A3","C421R, C420R","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 5, 2019)","criteria provided, single submitter","VCV000008585","16","56913065","16","56879153",8585,"23624","rs28936387","NC_000016.10:56879152:T:C"
"NM_001126108.2(SLC12A3):c.625C>T (p.Arg209Trp)","SLC12A3","R209W, R208W","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 6, 2020)","criteria provided, single submitter","VCV000008586","16","56904031","16","56870119",8586,"23625","rs28936388","NC_000016.10:56870118:C:T"
"NM_001009944.3(PKD1):c.7642G>C (p.Glu2548Gln)","PKD1","E2548Q","not specified|not provided|Polycystic kidney disease|Polycystic kidney disease, adult type","Benign/Likely benign(Last reviewed: Jun 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000257002","16","2156153","16","2106152",257002,"255584","rs28369051","NC_000016.10:2106151:C:G"
"NM_000135.4(FANCA):c.2021C>T (p.Ser674Leu)","FANCA","S674L","not specified|Fanconi anemia","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000237038","16","89838216","16","89771808",237038,"242547","rs17232973","NC_000016.10:89771807:G:A"
"NM_000422.3(KRT17):c.296T>C (p.Leu99Pro)","KRT17","L99P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Jun 9, 2015)","criteria provided, single submitter","VCV000014598","17","39780466","17","41624214",14598,"29637","rs28933089","NC_000017.11:41624213:A:G"
"NM_005557.4(KRT16):c.383T>A (p.Leu128Gln)","KRT16","L128Q","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000014609","17","39768558","17","41612306",14609,"29648","rs28928895","NC_000017.11:41612305:A:T"
"NM_000422.3(KRT17):c.284T>C (p.Leu95Pro)","KRT17","L95P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 14, 2015)","criteria provided, single submitter","VCV000014596","17","39780478","17","41624226",14596,"29635","rs28928899","NC_000017.11:41624225:A:G"
"NM_000422.3(KRT17):c.284T>A (p.Leu95Gln)","KRT17","L95Q","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014595","17","39780478","17","41624226",14595,"29634","rs28928899","NC_000017.11:41624225:A:T"
"NM_000546.6(TP53):c.844C>T (p.Arg282Trp)","TP53","R282W, R150W, R243W, R123W","Hereditary cancer-predisposing syndrome|Malignant melanoma of skin|Hepatocellular carcinoma|Renal cell carcinoma, papillary, 1|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Non-Hodgkin lymphoma|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Pleomorphic xanthoastrocytoma|Astrocytoma, anaplastic|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Glioblastoma|Li-Fraumeni-like syndrome|Neoplasm of ovary|Adenocarcinoma of stomach|Colorectal cancer|Carcinoma of esophagus","Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012364","17","7577094","17","7673776",12364,"27403","rs28934574","NC_000017.11:7673775:G:A"
"NM_000546.5(TP53):c.770T>A (p.Leu257Gln)","TP53","L257Q, L125Q, L218Q, L98Q","Li-Fraumeni-like syndrome|Neoplasm of ovary|Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Sep 3, 2016)","criteria provided, single submitter","VCV000012372","17","7577511","17","7674193",12372,"27411","rs28934577","NC_000017.11:7674192:A:T"
"NM_000346.4(SOX9):c.507C>T (p.His169=)","SOX9","","not specified|Camptomelic dysplasia|none provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021164","17","70118935","17","72122794",21164,"34016","rs2229989","NC_000017.11:72122793:C:T"
"NM_007294.4(BRCA1):c.5123C>T (p.Ala1708Val)","BRCA1","A1708V, A1661V, A1729V, A604V","Breast-ovarian cancer, familial 1|Craniopharyngioma|Hereditary breast and ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|Malignant tumor of breast","Uncertain significance(Last reviewed: Apr 19, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037640","17","41215920","17","43063903",37640,"46196","rs28897696","NC_000017.11:43063902:G:A"
"NM_000342.3(SLC4A1):c.2608C>T (p.Arg870Trp)","SLC4A1","R870W","Spherocytosis type 4|not provided","Likely pathogenic(Last reviewed: Jan 15, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017776","17","42328574","17","44251206",17776,"32815","rs28931585","NC_000017.11:44251205:G:A"
"NM_000342.4(SLC4A1):c.166A>G (p.Lys56Glu)","SLC4A1","K56E","not provided|not specified|Hemolytic anemia|none provided|Spherocytosis type 4|Band 3 memphis|Autosomal dominant distal renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017752","17","42338945","17","44261577",17752,"32791","rs5036","NC_000017.11:44261576:T:C"
"NM_000342.4(SLC4A1):c.2561C>T (p.Pro854Leu)","SLC4A1","P854L","Spherocytosis type 4|not provided|not specified|Autosomal dominant distal renal tubular acidosis|DIEGO BLOOD GROUP ANTIGEN|Hemolytic anemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000017768","17","42328621","17","44251253",17768,"32807","rs2285644","NC_000017.11:44251252:G:A"
"NM_000304.4(PMP22):c.469C>T (p.Arg157Trp)","PMP22","R157W","Charcot-Marie-Tooth disease, type I|Hereditary liability to pressure palsies|Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease and deafness|PMP22-Related Disorders","Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2020)","criteria provided, conflicting interpretations","VCV000008444","17","15134248","17","15230931",8444,"23483","rs28936682","NC_000017.11:15230930:G:A"
"NM_000286.3(PEX12):c.959C>T (p.Ser320Phe)","PEX12","S320F","not provided|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000007775","17","33902922","17","35575903",7775,"22814","rs28936697","NC_000017.11:35575902:G:A"
"NM_000546.5(TP53):c.770T>C (p.Leu257Pro)","TP53","L125P, L218P, L257P, L98P","Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Feb 12, 2019)","criteria provided, single submitter","VCV000458562","17","7577511","17","7674193",458562,"467516","rs28934577","NC_000017.11:7674192:A:G"
"NM_000304.4(PMP22):c.469C>G (p.Arg157Gly)","PMP22","R157G","Charcot-Marie-Tooth disease","Uncertain significance","no assertion criteria provided","VCV000637387","17","15134248","17","15230931",637387,"625362","rs28936682","NC_000017.11:15230930:G:C"
"NM_001614.5(ACTG1):c.773C>T (p.Pro258Leu)","ACTG1","P258L","not provided|Deafness, autosomal dominant 20|Baraitser-Winter Syndrome 2","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000639093","17","79478243","17","81511217",639093,"646969","rs11549191","NC_000017.11:81511216:G:A"
"NM_000546.5(TP53):c.844C>G (p.Arg282Gly)","TP53","R150G, R243G, R282G, R123G","Li-Fraumeni syndrome|Neoplasm of ovary|Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Breast neoplasm|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Hepatocellular carcinoma|Neoplasm of brain|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Neoplasm of the large intestine|Glioblastoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Squamous cell lung carcinoma|Lung adenocarcinoma|Non-Hodgkin lymphoma|Pancreatic adenocarcinoma","Pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000140821","17","7577094","17","7673776",140821,"150535","rs28934574","NC_000017.11:7673775:G:C"
"NM_000546.5(TP53):c.770T>G (p.Leu257Arg)","TP53","L125R, L218R, L257R, L98R","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2019)","criteria provided, conflicting interpretations","VCV000142134","17","7577511","17","7674193",142134,"151848","rs28934577","NC_000017.11:7674192:A:C"
"NM_007294.4(BRCA1):c.5123C>A (p.Ala1708Glu)","BRCA1","A1708E, A1661E, A1729E, A604E","Familial cancer of breast|none provided|Breast-ovarian cancer, familial 1|not provided|Breast neoplasm|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome","Pathogenic(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000055407","17","41215920","17","43063903",55407,"70074","rs28897696","NC_000017.11:43063902:G:T"
"NM_005557.4(KRT16):c.383T>C (p.Leu128Pro)","KRT16","L128P","not provided","Pathogenic(Last reviewed: Aug 1, 2016)","criteria provided, single submitter","VCV000265486","17","39768558","17","41612306",265486,"260164","rs28928895","NC_000017.11:41612305:A:G"
"NM_000346.4(SOX9):c.507C>G (p.His169Gln)","SOX9","H169Q","not provided|Camptomelic dysplasia|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000235914","17","70118935","17","72122794",235914,"237540","rs2229989","NC_000017.11:72122793:C:G"
"NM_000180.4(GUCY2D):c.3139-1G>C","GUCY2D","","not provided","Pathogenic(Last reviewed: Sep 29, 2016)","criteria provided, single submitter","VCV000280359","17","7919522","17","8016204",280359,"264708","rs12602083","NC_000017.11:8016203:G:C"
"NM_005912.2(MC4R):c.110A>T (p.Asp37Val)","MC4R","D37V","not specified|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity","Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)","criteria provided, conflicting interpretations","VCV000014319","18","58039473","18","60372240",14319,"29358","rs13447325","NC_000018.10:60372239:T:A"
"NM_005912.3(MC4R):c.380C>T (p.Ser127Leu)","MC4R","S127L","not provided|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2020)","criteria provided, conflicting interpretations","VCV000014336","18","58039203","18","60371970",14336,"29375","rs13447331","NC_000018.10:60371969:G:A"
"NM_000371.4(TTR):c.148G>A (p.Val50Met)","TTR","V50M","Charcot-Marie-Tooth disease|not provided|none provided|Cardiomyopathy|Amyloidogenic transthyretin amyloidosis|Amyloidogenic transthyretin amyloidosis|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome","Pathogenic(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000013417","18","29172937","18","31592974",13417,"28456","rs28933979","NC_000018.10:31592973:G:A"
"NM_000371.3(TTR):c.148G>C (p.Val50Leu)","TTR","V50L","Charcot-Marie-Tooth disease|Amyloidogenic transthyretin amyloidosis","Pathogenic","criteria provided, single submitter","VCV000013440","18","29172937","18","31592974",13440,"28479","rs28933979","NC_000018.10:31592973:G:C"
"NM_000894.2(LHB):c.221A>G (p.Gln74Arg)","LHB","Q74R","Isolated lutropin deficiency","Pathogenic(Last reviewed: Jan 16, 1992)","no assertion criteria provided","VCV000014413","19","49519530","19","49016273",14413,"29452","rs5030773","NC_000019.10:49016272:T:C"
"NM_000041.4(APOE):c.940A>C (p.Ser314Arg)","APOE","S314R, S340R","APOE4(+)","Pathogenic(Last reviewed: May 1, 1993)","no assertion criteria provided","VCV000017876","19","45412493","19","44909236",17876,"32915","rs28931579","NC_000019.10:44909235:A:C"
"NM_000095.3(COMP):c.2152C>T (p.Arg718Trp)","COMP","R718W","not provided|Carpal tunnel syndrome 2|Multiple epiphyseal dysplasia 1","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009198","19","18893939","19","18783129",9198,"24237","rs28936368","NC_000019.10:18783128:G:A"
"NM_000095.3(COMP):c.2152C>A (p.Arg718=)","COMP","","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia 1","Benign(Last reviewed: Oct 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000769450","19","18893939","19","18783129",769450,"704863","rs28936368","NC_000019.10:18783128:G:T"
"NM_000527.5(LDLR):c.2053C>A (p.Pro685Thr)","LDLR","P685T, P644T, P517T","Familial hypercholesterolemia 1","Likely pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, single submitter","VCV000252193","19","11231111","19","11120435",252193,"246488","rs2569548","NC_000019.10:11120434:C:A"
"NM_000527.5(LDLR):c.2053C>T (p.Pro685Ser)","LDLR","P685S, P644S, P517S","Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, multiple submitters, no conflicts","VCV000252194","19","11231111","19","11120435",252194,"246489","rs2569548","NC_000019.10:11120434:C:T"
"NM_000523.4(HOXD13):c.964A>C (p.Ile322Leu)","HOXD13","I322L","Brachydactyly type D|Brachydactyly type E1","Pathogenic(Last reviewed: Jan 27, 2006)","no assertion criteria provided","VCV000014869","2","176959390","2","176094662",14869,"29908","rs28928891","NC_000002.12:176094661:A:C"
"NM_000821.7(GGCX):c.1502G>C (p.Trp501Ser)","GGCX","W501S, W444S","Vitamin K-dependent clotting factors, combined deficiency of, 1","Pathogenic(Last reviewed: Nov 15, 2000)","no assertion criteria provided","VCV000016195","2","85779042","2","85551919",16195,"31234","rs28928872","NC_000002.12:85551918:C:G"
"NM_000104.3(CYP1B1):c.1405C>T (p.Arg469Trp)","CYP1B1","R469W","Glaucoma 3, primary congenital, A|not provided","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000007733","2","38298092","2","38070949",7733,"22772","rs28936701","NC_000002.12:38070948:G:A"
"NM_001201543.2(FAM161A):c.1212T>A (p.Cys404Ter)","FAM161A","C404*","Retinitis pigmentosa|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000425201","2","62066927","2","61839792",425201,"413535","rs4672457","NC_000002.12:61839791:A:T"
"NM_004304.5(ALK):c.4472A>G (p.Lys1491Arg)","ALK","K1491R, K423R","Hereditary cancer-predisposing syndrome|not specified|Squamous cell lung carcinoma|Neuroblastoma 3|not provided","Benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133474","2","29416481","2","29193615",133474,"137213","rs1881420","NC_000002.12:29193614:T:C"
"NM_004304.5(ALK):c.4587C>G (p.Asp1529Glu)","ALK","D1529E, D461E","Hereditary cancer-predisposing syndrome|not provided|Squamous cell lung carcinoma|not specified|Neuroblastoma 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133476","2","29416366","2","29193500",133476,"137215","rs1881421","NC_000002.12:29193499:G:C"
"NM_001201543.2(FAM161A):c.1212T>C (p.Cys404=)","FAM161A","","not provided|Retinitis pigmentosa 28|Retinitis pigmentosa|not specified","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000096217","2","62066927","2","61839792",96217,"102111","rs4672457","NC_000002.12:61839791:A:G"
"NM_000490.5(AVP):c.200T>C (p.Val67Ala)","AVP","V67A","Neurohypophyseal diabetes insipidus","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000012218","20","3063745","20","3083099",12218,"27257","rs28934878","NC_000020.11:3083098:A:G"
"NM_000311.5(PRNP):c.598G>A (p.Glu200Lys)","PRNP","E200K","Fatal familial insomnia|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|not provided","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013398","20","4680464","20","4699818",13398,"28437","rs28933385","NC_000020.11:4699817:G:A"
"NM_000557.5(GDF5):c.1322T>C (p.Leu441Pro)","GDF5|GDF5-AS1","L441P","Brachydactyly type A2|Fibular hypoplasia and complex brachydactyly","Pathogenic(Last reviewed: Mar 1, 2006)","no assertion criteria provided","VCV000008381","20","34021891","20","35434093",8381,"23420","rs28936683","NC_000020.11:35434092:A:G"
"NM_018419.3(SOX18):c.283T>A (p.Trp95Arg)","SOX18|TCEA2","W95R","Hypotrichosis-lymphedema-telangiectasia syndrome","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000008001","20","62680587","20","64049234",8001,"23040","rs28936693","NC_000020.11:64049233:A:T"
"NM_000214.3(JAG1):c.765C>T (p.Tyr255=)","JAG1","","Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease|not specified|Alagille syndrome 1|not provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000143063","20","10633237","20","10652589",143063,"152781","rs1131695","NC_000020.11:10652588:G:A"
"NM_000214.3(JAG1):c.765= (p.Tyr255=)","JAG1","","not specified","Benign(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000163705","20","10633237","20","10652589",163705,"176595","rs1131695","NC_000020.11:10652588:G:G"
"NM_000214.3(JAG1):c.765C>G (p.Tyr255Ter)","JAG1","Y255*","not provided","Pathogenic(Last reviewed: Oct 1, 2015)","criteria provided, single submitter","VCV000234555","20","10633237","20","10652589",234555,"232108","rs1131695","NC_000020.11:10652588:G:C"
"NM_000071.3(CBS):c.833T>C (p.Ile278Thr)","CBS","I278T, I173T","Homocystinuria|Classic homocystinuria|Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|none provided|Intellectual disability|Cardiovascular phenotype|not provided","Pathogenic(Last reviewed: Oct 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000120","21","44483184","21","43063074",120,"15159","rs5742905","NC_000021.9:43063073:A:G"
"NM_000211.5(ITGB2):c.1756C>T (p.Arg586Trp)","ITGB2","R586W, R517W","Leukocyte adhesion deficiency 1","Benign/Likely benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009463","21","46309312","21","44889397",9463,"24502","rs5030672","NC_000021.9:44889396:G:A"
"NM_020070.4(IGLL1):c.425C>T (p.Pro142Leu)","IGLL1","P142L, P143L","not specified|not provided|Agammaglobulinemia 2, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2020)","criteria provided, conflicting interpretations","VCV000014825","22","23915670","22","23573483",14825,"29864","rs1064422","NC_000022.11:23573482:G:A"
"NM_016335.5(PRODH):c.1322T>C (p.Leu441Pro)","PRODH","L441P, L333P","not provided|Schizophrenia 4|Proline dehydrogenase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)","criteria provided, conflicting interpretations","VCV000004008","22","18905934","22","18918421",4008,"19047","rs2904551","NC_000022.11:18918420:A:G"
"NM_016335.6(PRODH):c.1562= (p.Arg521=)","PRODH","","Proline dehydrogenase deficiency|not provided|Schizophrenia 4","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000004010","22","18901004","22","18913491",4010,"19049","rs450046","NC_000022.11:18913490:C:C"
"NM_152299.4(NCAPH2):c.*526G>A","SCO2|NCAPH2","R171W","Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency","Pathogenic(Last reviewed: Mar 22, 2000)","no assertion criteria provided","VCV000005680","22","50962330","22","50523901",5680,"20719","rs28937598","NC_000022.11:50523900:G:A"
"NM_007194.4(CHEK2):c.349A>G (p.Arg117Gly)","CHEK2","R117G, R160G","Malignant tumor of breast|CHEK2-Related Cancer Susceptibility|Breast cancer, susceptibility to|Prostate cancer, susceptibility to|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Hereditary breast and ovarian cancer syndrome|Predisposition to cancer","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2021)","criteria provided, multiple submitters, no conflicts","VCV000128071","22","29121326","22","28725338",128071,"133528","rs28909982","NC_000022.11:28725337:T:C"
"NM_000174.4(GP9):c.167T>C (p.Leu56Pro)","GP9","L40P, L56P","Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000013532","3","128780749","3","129061906",13532,"28571","rs28933377","NC_000003.12:129061905:T:C"
"NM_000539.3(RHO):c.632A>C (p.His211Pro)","RHO","H211P","Retinal dystrophy|Retinitis pigmentosa 4","Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013027","3","129251195","3","129532352",13027,"28066","rs28933993","NC_000003.12:129532351:A:C"
"NM_000539.3(RHO):c.158C>G (p.Pro53Arg)","RHO","P53R","Retinitis pigmentosa 4|Retinitis pigmentosa","Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)","no assertion criteria provided","VCV000013037","3","129247734","3","129528891",13037,"28076","rs28933395","NC_000003.12:129528890:C:G"
"NM_003242.6(TGFBR2):c.923T>C (p.Leu308Pro)","TGFBR2","L308P, L333P","Loeys-Dietz syndrome 2","Pathogenic(Last reviewed: Apr 1, 2010)","no assertion criteria provided","VCV000012505","3","30713598","3","30672106",12505,"27544","rs28934568","NC_000003.12:30672105:T:C"
"NM_001337.4(CX3CR1):c.839C>T (p.Thr280Met)","CX3CR1","T280M, T312M","","no interpretation for the single variant","no interpretation for the single variant","VCV000025511","3","39307162","3","39265671",25511,"36774","rs3732378","NC_000003.12:39265670:G:A"
"NM_000551.4(VHL):c.464-1G>A","VHL|LOC107303340","","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043603","3","10191470","3","10149786",43603,"52772","rs5030817","NC_000003.12:10149785:G:A"
"NM_000340.2(SLC2A2):c.1268T>A (p.Val423Glu)","SLC2A2","V423E, V250E, V304E","Fanconi-Bickel syndrome","Pathogenic(Last reviewed: Nov 1, 2000)","no assertion criteria provided","VCV000016101","3","170716088","3","170998299",16101,"31140","rs28928874","NC_000003.12:170998298:A:T"
"NM_020208.4(SLC6A20):c.596C>T (p.Thr199Met)","SLC6A20","T199M","Hyperglycinuria|Iminoglycinuria, digenic","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000004845","3","45814094","3","45772602",4845,"19884","rs17279437","NC_000003.12:45772601:G:A"
"NM_016362.5(GHRL):c.214C>A (p.Leu72Met)","GHRLOS|GHRL","L72M, L60M, L59M, L71M","Metabolic syndrome, susceptibility to|Obesity, age at onset of","Pathogenic, risk factor(Last reviewed: Dec 1, 2005)","no assertion criteria provided","VCV000005062","3","10331457","3","10289773",5062,"20101","rs696217","NC_000003.12:10289772:G:T"
"NM_003907.3(EIF2B5):c.1882T>C (p.Trp628Arg)","EIF2B5","W628R","Leukoencephalopathy with vanishing white matter","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000005943","3","183861899","3","184144111",5943,"20982","rs28937596","NC_000003.12:184144110:T:C"
"NM_001457.4(FLNB):c.2251G>C (p.Gly751Arg)","FLNB","G751R","not specified|Atelosteogenesis type III","Likely pathogenic(Last reviewed: Jan 30, 2017)","criteria provided, single submitter","VCV000006402","3","58095354","3","58109627",6402,"21441","rs28937587","NC_000003.12:58109626:G:C"
"NM_000404.2(GLB1):c.367G>A","GLB1","G123R, G171R, G93R","Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000928","3","33110341","3","33068849",928,"15967","rs28934274","NC_000003.12:33068848:C:T"
"NM_000551.4(VHL):c.500G>A (p.Arg167Gln)","VHL|LOC107303340","R167Q, R126Q","Hereditary cancer-predisposing syndrome|not specified|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)","criteria provided, conflicting interpretations","VCV000002216","3","10191507","3","10149823",2216,"17255","rs5030821","NC_000003.12:10149822:G:A"
"NM_000551.3(VHL):c.292T>C (p.Tyr98His)","VHL","Y98H","Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Apr 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002223","3","10183823","3","10142139",2223,"17262","rs5030809","NC_000003.12:10142138:T:C"
"NM_000388.4(CASR):c.680G>T (p.Arg227Leu)","CASR","R227L","Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1|Neonatal severe hyperparathyroidism","Pathogenic(Last reviewed: Apr 2, 2020)","criteria provided, single submitter","VCV000008317","3","121980562","3","122261715",8317,"23356","rs28936684","NC_000003.12:122261714:G:T"
"NM_000388.4(CASR):c.680G>A (p.Arg227Gln)","CASR","R227Q","Hypocalciuric hypercalcemia, familial, type 1|Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1|not provided","Pathogenic(Last reviewed: Oct 15, 2018)","criteria provided, multiple submitters, no conflicts","VCV000008331","3","121980562","3","122261715",8331,"23370","rs28936684","NC_000003.12:122261714:G:A"
"NM_000551.3(VHL):c.500G>T (p.Arg167Leu)","VHL|LOC107303340","R167L, R126L","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 14, 2017)","criteria provided, single submitter","VCV000526685","3","10191507","3","10149823",526685,"518692","rs5030821","NC_000003.12:10149822:G:T"
"NM_000551.3(VHL):c.500G>C (p.Arg167Pro)","LOC107303340|VHL","R167P, R126P","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428799","3","10191507","3","10149823",428799,"420451","rs5030821","NC_000003.12:10149822:G:C"
"NM_001063.4(TF):c.1623-63del","TF","","Atransferrinemia","Likely pathogenic(Last reviewed: Nov 14, 2019)","no assertion criteria provided","VCV000694735","3","133489289","3","133770445",694735,"682854","rs8177291","NC_000003.12:133770444:T:"
"NM_020949.3(SLC7A14):c.988G>A (p.Gly330Arg)","SLC7A14|SLC7A14-AS1","G330R","Retinitis pigmentosa 68|not provided","Benign(Last reviewed: Nov 14, 2020)","criteria provided, single submitter","VCV000126446","3","170201230","3","170483441",126446,"131974","rs2276717","NC_000003.12:170483440:C:T"
"NM_000313.3(PROS1):c.233C>T (p.Thr78Met)","PROS1","T78M, T110M","Protein S deficiency disease|Deep venous thrombosis|Thrombophilia due to protein S deficiency, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2020)","criteria provided, conflicting interpretations","VCV000215991","3","93646095","3","93927251",215991,"212340","rs6122","NC_000003.12:93927250:G:A"
"NM_000551.3(VHL):c.464-1G>C","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 31, 2019)","criteria provided, single submitter","VCV000223220","3","10191470","3","10149786",223220,"224951","rs5030817","NC_000003.12:10149785:G:C"
"NM_000551.3(VHL):c.464-1G>T","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 26, 2016)","no assertion criteria provided","VCV000223221","3","10191470","3","10149786",223221,"224952","rs5030817","NC_000003.12:10149785:G:T"
"NM_000551.4(VHL):c.464-2A>G","VHL|LOC107303340","","not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Pheochromocytoma|Erythrocytosis, familial, 2|Renal cell carcinoma, nonpapillary|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jun 30, 2021)","criteria provided, multiple submitters, no conflicts","VCV000223222","3","10191469","3","10149785",223222,"224950","rs5030816","NC_000003.12:10149784:A:G"
"NM_002448.3(MSX1):c.251A>T (p.Glu84Val)","MSX1","E84V","Orofacial cleft 5","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000014883","4","4861877","4","4860150",14883,"29922","rs28928890","NC_000004.12:4860149:A:T"
"NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)","FGFR3","P250R","Craniosynostosis syndrome|not specified|not provided|Saethre-Chotzen syndrome|Muenke syndrome|Hypochondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Inborn genetic diseases|Achondroplasia|Coronal craniosynostosis|Crouzon syndrome|Facial asymmetry|Infantile axial hypotonia|Absence seizures|Unilateral renal agenesis|Seizures","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016340","4","1803571","4","1801844",16340,"31379","rs4647924","NC_000004.12:1801843:C:G"
"NM_021870.3(FGG):c.571G>A (p.Gly191Arg)","FGG","G191R","not specified|not provided|Hypofibrinogenemia|Afibrinogenemia, congenital|Fibrinogen Milano XII, digenic","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000016378","4","155530877","4","154609725",16378,"31417","rs6063","NC_000004.12:154609724:C:T"
"NM_006005.3(WFS1):c.461-9A>G","WFS1","","WFS1-Related Spectrum Disorders|not specified|none provided|not provided|Type 2 diabetes mellitus|Autosomal dominant nonsyndromic deafness 6","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004527","4","6292915","4","6291188",4527,"19566","rs10010131","NC_000004.12:6291187:A:G"
"NM_000142.5(FGFR3):c.749C>T (p.Pro250Leu)","FGFR3","P250L","Craniosynostosis syndrome","Uncertain significance(Last reviewed: Oct 2, 2017)","criteria provided, single submitter","VCV000533893","4","1803571","4","1801844",533893,"519844","rs4647924","NC_000004.12:1801843:C:T"
"NM_000203.5(IDUA):c.1225G>C (p.Gly409Arg)","IDUA","G409R, G277R","not provided|not specified|Mucopolysaccharidosis type 1|Hurler syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)","criteria provided, conflicting interpretations","VCV000092627","4","996555","4","1002767",92627,"26950","rs11934801","NC_000004.12:1002766:G:C"
"NM_213647.3(FGFR4):c.1162G>A (p.Gly388Arg)","FGFR4","G388R","Cancer progression and tumor cell motility|See cases","Uncertain significance(Last reviewed: Oct 17, 2019)","criteria provided, single submitter","VCV000016326","5","176520243","5","177093242",16326,"31365","rs351855","NC_000005.10:177093241:G:A"
"NM_000176.3(NR3C1):c.66G>A (p.Glu22=)","NR3C1","","Glucocorticoid resistance, generalized|Glucocorticoid resistance, relative","Benign/Likely benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000155925","5","142780339","5","143400774",155925,"31193","rs6189","NC_000005.10:143400773:C:T"
"NM_000500.9(CYP21A2):c.92C>T (p.Pro31Leu)","CYP21A2|LOC106780800","P31L","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Dec 17, 2019)","criteria provided, multiple submitters, no conflicts","VCV000012153","6","32006291","6","32038514",12153,"27192","rs9378251","NC_000006.12:32038513:C:T"
"NM_148919.4(PSMB8):c.145C>A (p.Gln49Lys)","PSMB8","Q49K","not specified|Proteasome-associated autoinflammatory syndrome 1","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000356368","6","32811629","6","32843852",356368,"302501","rs2071543","NC_000006.12:32843851:G:T"
"NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)","GLI3","A934P","Greig cephalopolysyndactyly syndrome, severe","Pathogenic(Last reviewed: Jun 1, 2006)","no assertion criteria provided","VCV000013825","7","42005871","7","41966273",13825,"28864","rs28933372","NC_000007.14:41966272:C:G"
"NM_172056.2(KCNH2):c.1778T>G (p.Ile593Arg)","KCNH2","I593R, I253R","Congenital long QT syndrome|not provided|Long QT syndrome 2","Pathogenic(Last reviewed: May 24, 2019)","criteria provided, single submitter","VCV000014423","7","150648703","7","150951615",14423,"29462","rs28928904","NC_000007.14:150951614:A:C"
"NM_172056.2(KCNH2):c.2350C>T (p.Arg784Trp)","KCNH2","R784W, R444W","Brugada syndrome|Arrhythmia|Long QT syndrome 2, acquired, susceptibility to|Long QT syndrome 2|Congenital long QT syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2021)","criteria provided, conflicting interpretations","VCV000014433","7","150647304","7","150950216",14433,"29472","rs12720441","NC_000007.14:150950215:G:A"
"NM_000941.3(POR):c.1370G>A (p.Arg457His)","POR","R457H","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency","Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)","criteria provided, multiple submitters, no conflicts","VCV000016907","7","75614497","7","75985179",16907,"31946","rs28931608","NC_000007.14:75985178:G:A"
"NM_000823.4(GHRHR):c.57+1G>A","GHRHR","","Isolated growth hormone deficiency, type 4","Pathogenic(Last reviewed: Dec 1, 2007)","no assertion criteria provided","VCV000015990","7","31003741","7","30964126",15990,"31029","rs2302022","NC_000007.14:30964125:G:A"
"NM_001540.5(HSPB1):c.545C>T (p.Pro182Leu)","HSPB1","P182L","Distal hereditary motor neuronopathy type 2B","Pathogenic(Last reviewed: Jan 15, 2006)","no assertion criteria provided","VCV000007481","7","75933417","7","76304100",7481,"22520","rs28937569","NC_000007.14:76304099:C:T"
"NM_001540.5(HSPB1):c.452C>T (p.Thr151Ile)","HSPB1","T151I","Charcot-Marie-Tooth disease|Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F","Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2018)","criteria provided, conflicting interpretations","VCV000007480","7","75933324","7","76304007",7480,"22519","rs28937568","NC_000007.14:76304006:C:T"
"NM_000193.4(SHH):c.91G>A (p.Gly31Arg)","SHH","G31R","Holoprosencephaly 3","Pathogenic(Last reviewed: Aug 29, 2013)","no assertion criteria provided","VCV000008877","7","155604726","7","155812032",8877,"23916","rs28936675","NC_000007.14:155812031:C:T"
"NM_000492.3(CFTR):c.3485G>A (p.Arg1162Gln)","CFTR","R1162Q","not provided|Cystic fibrosis","Uncertain significance(Last reviewed: Jan 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000555228","7","117267592","7","117627538",555228,"544211","rs1800120","NC_000007.14:117627537:G:A"
"NM_172056.2(KCNH2):c.1778T>A (p.Ile593Lys)","KCNH2","I253K, I593K","Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Jul 25, 2017)","criteria provided, single submitter","VCV000067269","7","150648703","7","150951615",67269,"78165","rs28928904","NC_000007.14:150951614:A:T"
"NM_172056.2(KCNH2):c.1778T>C (p.Ile593Thr)","KCNH2","I253T, I593T","Congenital long QT syndrome|not provided","Pathogenic(Last reviewed: Feb 2, 2014)","criteria provided, single submitter","VCV000067270","7","150648703","7","150951615",67270,"78166","rs28928904","NC_000007.14:150951614:A:G"
"NM_000492.4(CFTR):c.509G>A (p.Arg170His)","CFTR","R170H","Cystic fibrosis|Inborn genetic diseases|not provided|not specified|CFTR-related disorders|none provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 26, 2021)","criteria provided, conflicting interpretations","VCV000053983","7","117174349","7","117534295",53983,"68650","rs1800079","NC_000007.14:117534294:G:A"
"NM_000492.3(CFTR):c.3485G>T (p.Arg1162Leu)","CFTR","R1162L","Cystic fibrosis|Inborn genetic diseases|not provided|CFTR-related disorders|none provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2021)","criteria provided, conflicting interpretations","VCV000256253","7","117267592","7","117627538",256253,"252571","rs1800120","NC_000007.14:117627537:G:T"
"NM_000823.4(GHRHR):c.57+1G>T","GHRHR","","Isolated growth hormone deficiency type IB","Uncertain significance(Last reviewed: Sep 28, 2016)","criteria provided, single submitter","VCV000360028","7","31003741","7","30964126",360028,"310914","rs2302022","NC_000007.14:30964125:G:T"
"NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004602","8","143822617","8","142741199",4602,"19641","rs28937888","NC_000008.11:142741198:C:T"
"NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004603","8","143822617","8","142741199",4603,"19642","rs28937888","NC_000008.11:142741198:C:G"
"NM_020427.3(SLURP1):c.1A>C (p.Met1Leu)","SLURP1","M1L","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004604","8","143823803","8","142742385",4604,"19643","rs28937889","NC_000008.11:142742384:T:G"
"NM_012082.4(ZFPM2):c.1969A>G (p.Ser657Gly)","ZFPM2|ZFPM2-AS1","S657G, S525G, S604G","Tetralogy of Fallot|46,XY sex reversal 9","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006127","8","106814279","8","105802051",6127,"21166","rs28374544","NC_000008.11:105802050:A:G"
"NM_000498.3(CYP11B2):c.541C>T (p.Arg181Trp)","CYP11B2|LOC106799834","R181W","Corticosterone methyl oxidase type II deficiency|not provided","Uncertain significance(Last reviewed: Oct 25, 2020)","criteria provided, single submitter","VCV000242773","8","143996516","8","142915100",242773,"31915","rs28931609","NC_000008.11:142915099:G:A"
"NM_003235.5(TG):c.2443G>A (p.Gly815Arg)","TG","G815R","Iodotyrosyl coupling defect","Likely benign(Last reviewed: Jan 12, 2018)","criteria provided, single submitter","VCV000361924","8","133900495","8","132888250",361924,"304296","rs16904774","NC_000008.11:132888249:G:A"
"NM_003235.5(TG):c.2443G>T (p.Gly815Ter)","TG","G815*","not provided","Pathogenic(Last reviewed: Oct 20, 2016)","criteria provided, single submitter","VCV000372918","8","133900495","8","132888250",372918,"359830","rs16904774","NC_000008.11:132888249:G:T"
"NM_000031.6(ALAD):c.177G>C (p.Lys59Asn)","ALAD","K59N, K51N, K88N","not provided|Porphobilinogen synthase deficiency|AMINOLEVULINATE DEHYDRATASE, ALAD*1/ALAD*2 POLYMORPHISM","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016864","9","116153891","9","113391611",16864,"31903","rs1800435","NC_000009.12:113391610:C:G"
"NM_005476.7(GNE):c.2135T>C (p.Met712Thr)","GNE","M712T, M743T, M602T, M638T, M653T, M661T","not provided|GNE myopathy|Sialuria|GNE myopathy","Pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006025","9","36217396","9","36217399",6025,"21064","rs28937594","NC_000009.12:36217398:A:G"
"NM_019892.6(INPP5E):c.1543C>T (p.Arg515Trp)","INPP5E","R515W, R514W","Joubert syndrome 1","Pathogenic(Last reviewed: Sep 1, 2009)","no assertion criteria provided","VCV000000397","9","139326282","9","136431830",397,"15436","rs13297509","NC_000009.12:136431829:G:A"
"NM_005502.4(ABCA1):c.1790A>G (p.Gln597Arg)","ABCA1","Q597R","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009485","9","107593308","9","104831027",9485,"24524","rs2853578","NC_000009.12:104831026:T:C"
"NM_005502.4(ABCA1):c.2804A>G (p.Asn935Ser)","ABCA1","N935S","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009488","9","107584801","9","104822520",9488,"24527","rs28937313","NC_000009.12:104822519:T:C"
"NM_012144.4(DNAI1):c.1003G>T (p.Val335Phe)","DNAI1","V335F, V339F","Kartagener syndrome|Primary ciliary dyskinesia","Uncertain significance(Last reviewed: Dec 1, 2017)","criteria provided, single submitter","VCV000525451","9","34500821","9","34500823",525451,"525082","rs11793196","NC_000009.12:34500822:G:T"
"NM_000077.4(CDKN2A):c.-34G>A","CDKN2A","","Melanoma-pancreatic cancer syndrome|Hereditary melanoma|not specified","Likely benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379882","9","21974860","9","21974861",379882,"371197","rs1800586","NC_000009.12:21974860:C:T"
"NM_005502.4(ABCA1):c.1759C>T (p.Arg587Trp)","ABCA1","R587W","ABCA1-Related Disorders","Pathogenic(Last reviewed: Jan 11, 2019)","criteria provided, single submitter","VCV000632033","9","107593339","9","104831058",632033,"620315","rs2853574","NC_000009.12:104831057:G:A"
"NM_004629.1(FANCG):c.1538G>A (p.Arg513Gln)","FANCG|VCP","R513Q","not provided|not specified|Fanconi anemia, complementation group G|Amyotrophic Lateral Sclerosis, Dominant|Fanconi anemia|Inclusion Body Myopathy, Dominant","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000134361","9","35075022","9","35075025",134361,"138100","rs17885240","NC_000009.12:35075024:C:T"
"NM_000077.4(CDKN2A):c.-34G>T","CDKN2A","","Cutaneous malignant melanoma 2|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome|Melanoma-pancreatic cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary melanoma","Pathogenic(Last reviewed: Oct 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182414","9","21974860","9","21974861",182414,"180325","rs1800586","NC_000009.12:21974860:C:A"
"NM_012144.4(DNAI1):c.1003G>A (p.Val335Ile)","DNAI1","V335I, V339I","not specified|Primary ciliary dyskinesia|Kartagener syndrome","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000163164","9","34500821","9","34500823",163164,"175107","rs11793196","NC_000009.12:34500822:G:A"
"NM_019892.6(INPP5E):c.1543C>A (p.Arg515=)","INPP5E","","not specified","Likely benign","criteria provided, single submitter","VCV000261196","9","139326282","9","136431830",261196,"253469","rs13297509","NC_000009.12:136431829:G:T"
"NM_000077.4(CDKN2A):c.-34G>C","CDKN2A","","Hereditary melanoma|Melanoma-pancreatic cancer syndrome|not specified|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000245907","9","21974860","9","21974861",245907,"244550","rs1800586","NC_000009.12:21974860:C:G"
"NM_000132.3(F8):c.5822A>G (p.Asn1941Ser)","F8","N1941S","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 9, 2020)","criteria provided, single submitter","VCV000010294","X","154132357","X","154904082",10294,"25333","rs28933682","NC_000023.11:154904081:T:C"
"NM_000169.2(GLA):c.484T>C (p.Trp162Arg)","GLA|RPL36A-HNRNPH2","W162R","Fabry disease","Likely pathogenic(Last reviewed: Jul 2, 2018)","criteria provided, single submitter","VCV000010728","X","100656683","X","101401695",10728,"25767","rs28935196","NC_000023.11:101401694:A:G"
"NM_000132.3(F8):c.1226A>G (p.Glu409Gly)","F8","E409G","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010209","X","154194746","X","154966471",10209,"25248","rs28933671","NC_000023.11:154966470:T:C"
"NM_000132.3(F8):c.2215G>A (p.Glu739Lys)","F8","E739K","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010247","X","154159850","X","154931575",10247,"25286","rs28937285","NC_000023.11:154931574:C:T"
"NM_004429.4(EFNB1):c.472A>G (p.Met158Val)","EFNB1","M158V","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011711","X","68059572","X","68839729",11711,"26750","rs28936071","NC_000023.11:68839728:A:G"
"NM_014009.3(FOXP3):c.1189C>T (p.Arg397Trp)","FOXP3","R397W, R362W","Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Hydrops fetalis","Pathogenic(Last reviewed: Mar 2, 2020)","criteria provided, single submitter","VCV000011407","X","49107902","X","49251441",11407,"26446","rs28935477","NC_000023.11:49251440:G:A"
"NM_006579.3(EBP):c.440G>A (p.Arg147His)","EBP","R147H","Chondrodysplasia punctata 2 X-linked dominant","Pathogenic(Last reviewed: Feb 8, 2013)","criteria provided, single submitter","VCV000011492","X","48385644","X","48527256",11492,"26531","rs28935174","NC_000023.11:48527255:G:A"
"NM_001110556.2(FLNA):c.245A>T (p.Glu82Val)","FLNA","E82V","Periventricular nodular heterotopia 1","Pathogenic(Last reviewed: Mar 26, 2002)","no assertion criteria provided","VCV000011754","X","153599369","X","154371001",11754,"26793","rs28935169","NC_000023.11:154371000:T:A"
"NM_001110556.2(FLNA):c.620C>T (p.Pro207Leu)","FLNA","P207L","not specified|Oto-palato-digital syndrome, type I|Cleft palate|Conductive hearing impairment|Short stature","Pathogenic(Last reviewed: Nov 20, 2018)","criteria provided, multiple submitters, no conflicts","VCV000011755","X","153596212","X","154367844",11755,"26794","rs28935469","NC_000023.11:154367843:G:A"
"NM_001110556.2(FLNA):c.3596C>T (p.Ser1199Leu)","FLNA","S1199L","Oto-palato-digital syndrome, type II|Melnick-Needles syndrome|Melnick-Needles syndrome|Frontometaphyseal dysplasia|Periventricular nodular heterotopia 1|Oto-palato-digital syndrome, type II","Pathogenic(Last reviewed: Dec 23, 2016)","criteria provided, multiple submitters, no conflicts","VCV000011759","X","153588567","X","154360199",11759,"26798","rs28935473","NC_000023.11:154360198:G:A"
"NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)","MECP2","T158M, T170M, T65M","History of neurodevelopmental disorder|Angelman syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|not provided|not specified|Autism, susceptibility to, X-linked 3","Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011811","X","153296806","X","154031355",11811,"26850","rs28934906","NC_000023.11:154031354:G:A"
"NM_001110792.2(MECP2):c.352C>T (p.Arg118Trp)","MECP2","R106W, R118W, R13W","not provided|Autism, susceptibility to, X-linked 3|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder|not specified","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011814","X","153297719","X","154032268",11814,"26853","rs28934907","NC_000023.11:154032267:G:A"
"NM_000533.5(PLP1):c.44C>T (p.Pro15Leu)","PLP1|RAB9B","P15L","Pelizaeus-Merzbacher disease","Pathogenic(Last reviewed: Dec 1, 1989)","no assertion criteria provided","VCV000011075","X","103040550","X","103785621",11075,"26114","rs11543022","NC_000023.11:103785620:C:T"
"NM_139058.3(ARX):c.98T>C (p.Leu33Pro)","ARX","L33P","Mental retardation, with or without seizures, ARX-related, X-linked","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000011198","X","25033757","X","25015640",11198,"26237","rs28936077","NC_000023.11:25015639:A:G"
"NM_000033.4(ABCD1):c.1850G>A (p.Arg617His)","ABCD1","R617H","not provided|none provided|Adrenoleukodystrophy","Pathogenic(Last reviewed: Oct 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011312","X","153008510","X","153743056",11312,"26351","rs11146842","NC_000023.11:153743055:G:A"
"NM_000033.4(ABCD1):c.1849C>T (p.Arg617Cys)","ABCD1","R617C","Adrenoleukodystrophy|none provided|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011313","X","153008509","X","153743055",11313,"26352","rs4010613","NC_000023.11:153743054:C:T"
"NM_000061.2(BTK):c.370T>C (p.Trp124Arg)","BTK","W124R, W158R","not provided","Likely pathogenic(Last reviewed: Nov 11, 2015)","criteria provided, single submitter","VCV000381633","X","100625007","X","101370019",381633,"378793","rs7474275","NC_000023.11:101370018:A:G"
"NM_014009.4(FOXP3):c.155G>T (p.Gly52Val)","FOXP3","G52V","Non-obstructive azoospermia|Insulin-dependent diabetes mellitus secretory diarrhea syndrome","Benign(Last reviewed: Nov 23, 2020)","criteria provided, single submitter","VCV000712945","X","49114808","X","49258351",712945,"729636","rs17847095","NC_000023.11:49258350:C:A"
"NM_001110792.2(MECP2):c.352C>G (p.Arg118Gly)","MECP2","R106G, R118G, R13G","Rett syndrome","Uncertain significance(Last reviewed: Jan 21, 2008)","no assertion criteria provided","VCV000143533","X","153297719","X","154032268",143533,"153265","rs28934907","NC_000023.11:154032267:G:C"
"NM_001323289.2(CDKL5):c.2494C>T (p.Gln832Ter)","CDKL5","Q832*","Early infantile epileptic encephalopathy 2","Pathogenic(Last reviewed: Mar 13, 2014)","no assertion criteria provided","VCV000189573","X","18643365","X","18625245",189573,"187625","rs17857094","NC_000023.11:18625244:C:T"
